Global Neuroendocrine Tumors Market Size, Share, and COVID-19 Impact Analysis, By Product (Somatostatin Analogs, Targeted Therapy, and Chemotherapy), By End User (Hospitals, Specialty Clinics, Radiation Centers, Home Healthcare, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Jun 2025
REPORT ID SI11840
PAGES 210
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Product
      2. Market Attractiveness Analysis By End User
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising Incidence & Better Diagnosis
    3. Restraints
      1.  High Treatment Costs
    4. Opportunities
      1.  Companion Diagnostics & Biomarker Integration
    5. Challenges

5.5.1.     Limited Patient Awareness and Late Diagnosis

  1. Global Neuroendocrine Tumors Market Analysis and Projection, By Product
    1. Segment Overview
    2.  Somatostatin Analogs
    3. Targeted Therapy
    4. Chemotherapy
  2. Global Neuroendocrine Tumors Market Analysis and Projection, By End User
    1. Segment Overview
    2. Hospitals
    3. Specialty Clinics
    4. Radiation Centers
    5. Home Healthcare
    6. Others
  3. Global Neuroendocrine Tumors Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  4. Global Neuroendocrine Tumors Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Neuroendocrine Tumors Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  5. Company Profiles
    1. Lupin
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Lilly 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  HUTCHMED 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   GSK plc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Pfizer Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  BioSynthema Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Exact Sciences Corporation
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Ipsen Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Bionano Genomics, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Illumina, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Teva Pharmaceutical Industries Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Sun Pharmaceutical Industries Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Regeneron Pharmaceuticals, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Advanced Accelerator Applications SA
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  2. Global Somatostatin Analogs, Neuroendocrine Tumors Market, By Region, 2024-2035(USD Billion)
  3. Global Targeted Therapy, Neuroendocrine Tumors Market, By Region, 2024-2035(USD Billion)
  4. Global Chemotherapy, Neuroendocrine Tumors Market, By Region, 2024-2035(USD Billion)
  5. Global Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  6. Global Hospitals, Neuroendocrine Tumors Market, By Region, 2024-2035(USD Billion)
  7. Global Specialty Clinics, Neuroendocrine Tumors Market, By Region, 2024-2035(USD Billion)
  8. Global Radiation Centers, Neuroendocrine Tumors Market, By Region, 2024-2035(USD Billion)
  9. Global Home Healthcare, Neuroendocrine Tumors Market, By Region, 2024-2035(USD Billion)
  10. Global Others, Neuroendocrine Tumors Market, By Region, 2024-2035(USD Billion)
  11. North America Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  12. North America Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  13. U.S.  Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  14. U.S.  Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  15. Canada Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  16. Canada Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  17. Mexico Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  18. Mexico Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  19. Europe Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  20. Europe Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  21. Germany Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  22. Germany Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  23. France Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  24. France Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  25. U.K.  Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  26. U.K.  Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  27. Italy Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  28. Italy Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  29. Spain Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  30. Spain Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  31. Asia Pacific Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  32. Asia Pacific Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  33. Japan Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  34. Japan Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  35. China Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  36. China Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  37. India Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  38. India Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  39. South America Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  40. South America Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  41. Brazil Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  42. Brazil Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  43. The Middle East and Africa Neuroendocrine Tumors Market, By Product, 2024-2035(USD   Billion)
  44. The Middle East and Africa Neuroendocrine Tumors Market, By End User, 2024-2035(USD   Billion)
  45. UAE Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  46. UAE Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)
  47. South Africa Neuroendocrine Tumors Market, By Product, 2024-2035(USD Billion)
  48. South Africa Neuroendocrine Tumors Market, By End User, 2024-2035(USD Billion)

List of Figures 

  1. Global Neuroendocrine Tumors Market Segmentation
  2. Neuroendocrine Tumors Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Neuroendocrine Tumors Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Neuroendocrine Tumors Market
  20. Neuroendocrine Tumors Market Segmentation, By Product
  21. Neuroendocrine Tumors Market For Somatostatin Analogs, By Region, 2024-2035 ($ Billion)
  22.  Neuroendocrine Tumors Market For Targeted Therapy, By Region, 2024-2035 ($ Billion)
  23. Neuroendocrine Tumors Market For Chemotherapy, By Region, 2024-2035 ($ Billion)
  24. Neuroendocrine Tumors Market Segmentation, By End User
  25.  Neuroendocrine Tumors Market For Hospitals, By Region, 2024-2035 ($ Billion)
  26.  Neuroendocrine Tumors Market For Specialty Clinics, By Region, 2024-2035 ($ Billion)
  27. Neuroendocrine Tumors Market For Radiation Centers, By Region, 2024-2035 ($ Billion)
  28. Neuroendocrine Tumors Market For Home Healthcare, By Region, 2024-2035 ($ Billion)
  29. Neuroendocrine Tumors Market For Others, By Region, 2024-2035 ($ Billion)
  30. Lupin: Net Sales, 2024-2035 ($ Billion)
  31. Lupin: Revenue Share, By Segment, 2024 (%)
  32. Lupin: Revenue Share, By Region, 2024 (%)
  33. Lilly: Net Sales, 2024-2035 ($ Billion)
  34. Lilly: Revenue Share, By Segment, 2024 (%)
  35. Lilly: Revenue Share, By Region, 2024 (%)
  36. HUTCHMED: Net Sales, 2024-2035 ($ Billion)
  37. HUTCHMED: Revenue Share, By Segment, 2024 (%)
  38. HUTCHMED: Revenue Share, By Region, 2024 (%)
  39. GSK plc: Net Sales, 2024-2035 ($ Billion)
  40. GSK plc: Revenue Share, By Segment, 2024 (%)
  41. GSK plc: Revenue Share, By Region, 2024 (%)
  42. Pfizer Inc.: Net Sales, 2024-2035 ($ Billion)
  43. Pfizer Inc.: Revenue Share, By Segment, 2024 (%)
  44. Pfizer Inc.: Revenue Share, By Region, 2024 (%)
  45. BioSynthema Inc.: Net Sales, 2024-2035 ($ Billion)
  46. BioSynthema Inc.: Revenue Share, By Segment, 2024 (%)
  47. BioSynthema Inc.: Revenue Share, By Region, 2024 (%)
  48. Exact Sciences Corporation: Net Sales, 2024-2035 ($ Billion)
  49. Exact Sciences Corporation: Revenue Share, By Segment, 2024 (%)
  50. Exact Sciences Corporation: Revenue Share, By Region, 2024 (%)
  51. Ipsen Pharma: Net Sales, 2024-2035 ($ Billion)
  52. Ipsen Pharma: Revenue Share, By Segment, 2024 (%)
  53. Ipsen Pharma: Revenue Share, By Region, 2024 (%)
  54. Bionano Genomics, Inc..: Net Sales, 2024-2035 ($ Billion)
  55. Bionano Genomics, Inc..: Revenue Share, By Segment, 2024 (%)
  56. Bionano Genomics, Inc..: Revenue Share, By Region, 2024 (%)
  57. Illumina, Inc.: Net Sales, 2024-2035 ($ Billion)
  58. Illumina, Inc.: Revenue Share, By Segment, 2024 (%)
  59. Illumina, Inc.: Revenue Share, By Region, 2024 (%)
  60. Teva Pharmaceutical Industries Ltd.: Net Sales, 2024-2035 ($ Billion)
  61. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2024 (%)
  62. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2024 (%)
  63. Sun Pharmaceutical Industries Ltd.: Net Sales, 2024-2035 ($ Billion)
  64. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2024 (%)
  65. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2024 (%)
  66. Regeneron Pharmaceuticals, Inc.: Net Sales, 2024-2035 ($ Billion)
  67. Regeneron Pharmaceuticals, Inc.: Revenue Share, By Segment, 2024 (%)
  68. Regeneron Pharmaceuticals, Inc.: Revenue Share, By Region, 2024 (%)
  69. Advanced Accelerator Applications SA: Net Sales, 2024-2035 ($ Billion)
  70. Advanced Accelerator Applications SA: Revenue Share, By Segment, 2024 (%)
  71. Advanced Accelerator Applications SA: Revenue Share, By Region, 2024 (%)
  72. Others: Net Sales, 2024-2035 ($ Billion)
  73. Others: Revenue Share, By Segment, 2024 (%)
  74. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:130
Pages:210
Countries covered:17
Companies covered::20
Forecast CAGR:10.30%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies